Utama › Hipertensi Pulmonari › Kentucky
Kajian klinikal Hipertensi Pulmonari di Kentucky
7 kajian untuk Hipertensi Pulmonari sedang mencari peserta di lokasi di Kentucky.
Bandar di Kentucky
Teks kajian rasmi (Bahasa Inggeris)
A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)
- Clinical Research Site, Louisville
Mengambil pesertaFasa 3
Umur 18 hingga 85 · Semua jantina · Dikemas kini 11 Sep 2026 · NCT07816185Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
- University of Kentucky, Lexington
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Sep 2026 · NCT06911632DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Norton Pulmonary Specialists, Louisville
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 26 Ogo 2026 · NCT06388421De-implementing Inhaled Nitric Oxide for Congenital Diaphragmatic Hernia
- University of Louisville & Norton Children's Hospital (UL-NCH), Louisville
Mengambil pesertaFasa 4
0 Months – 1 Month · Semua jantina · Dikemas kini 18 Ogo 2026 · NCT05213676Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
- University of Kentucky, Lexington
- Norton Hospital, Louisville
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 10 Jun 2026 · NCT06526195Pulmonary Hypertension Association Registry
- Kentuckiana Pulmonary Associates, Louisville
Mengambil pesertaKajian pemerhatian
Umur 0 ke atas · Semua jantina · Dikemas kini 14 Nov 2025 · NCT04071327Study Roles of Heavy Metals and Essential Metal Dyshomeostasis in Pulmonary Arterial Hypertension Patients
- University of Louisville Health, Louisville
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Mei 2025 · NCT04756076Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.